Searched for
ONCOLOGY
Glenmark sees innovative products driving 70% revenue in 5-6 years: CMD Glenn SaldanhaGlenmark anticipates innovative products will drive nearly seventy percent of its revenue. This strategic shift moves the company away from...- Risk is integral to the market; but there are different kinds of risk: 6 mid-cap stocks with upside potential of up to 21%We are in uncertain and volatile times. Does that mean investors should just sit out the downturn? While that is an option, the better opti...
- Seoul Semicon’s India plans; Specialty healthcare attracts VCsSouth Korea's Seoul Semiconductor is planning a manufacturing foray in India. This and more in today's ETtech Top 5.
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%It may take a while for clarity to emerge in the Gulf region. In the meantime, focus on fundamentals and how they pan out in the next coupl...
- For investors with 1- to 2-year perspective and ability to ignore volatility: 6 stocks with an upside potential of up to 26%The US-Iran war is escalating again, with all that means for crude prices and nervous markets. And halfway across the world, the long AI tr...
- NEET topper Panshul Bansal shares how Re-NEET helped him improve score from 706 to 715, secure better collegePanshul Bansal and Aryan Gupta jointly secured the top rank in the Re-NEET UG 2026 examination. Bansal stated the mandatory re-examination ...
- Poly Medicure bets on new facilities, products to double international business: MDThe company's international business contributed ₹1,280.2 crore in FY26, accounting for nearly 68% of the company's total revenue of ₹1,875...
- Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley dealEli Lilly will acquire AtaiBeckley for up to $3.8 billion. This deal aims to develop psychedelic treatments for depression and other mental...
- Match Your AI Strategy to Your Organization’s RealityArtificial intelligence is often hailed as a game changer, but too many firms discover that their bold AI pilots collapse when their operat...
- 'She can crawl with both hands': Bengaluru newborn saved from losing her right hand to rare cancer; strangers raise Rs 30 lakh for baby's tumour treatmentA Bengaluru newborn diagnosed with a rare and aggressive cancer faced the possibility of losing her hand just weeks after birth. A team of ...
- Global smart money can't get enough of India's next growth storyGlobal private equity firms are expanding beyond hospitals into India's broader healthcare ecosystem, with Warburg Pincus, TA Associates, B...
- For investors with an over 2-year perspective: 5 mid- and small-cap stocks with an upside potential of up to 26%This is a market to be selective in, not brave in. The safer way to play a turn in the market is to stay with businesses whose demand does ...
- HCG uses AI, patient data to personalise cancer treatment: BS Ajaikumar, founderHealthcare Global Enterprises is using artificial intelligence and patient data. Algorithms are being developed to personalise cancer treat...
- GA-Renova & CCA in race to buy American oncology: Siemens Healthineers looking to exit non-core business for Rs 1,500 croreTwo prominent players are in the running to purchase American Oncology Institute from Siemens Healthineers. One of the potential buyers is ...
- Psychology says people who believe in fairy tales aren't unrealistic: What this belief reveals?Psychology says people who believe in fairy tales are often viewed as unrealistic, but psychology presents a different explanation. Researc...
- Why Your Digital Investments Aren’t Creating ValueMany companies are pouring money into AI, analytics, and CRM platforms, yet struggle to translate those investments into measurable revenue...
- OnCare launches cancer treatment centre in BengaluruBengaluru now has a new cancer treatment centre launched by OnCare, aiming to bring accessible, affordable, and patient-friendly oncology s...
- Zydus Lifesciences ties up with Apollo Hospitals to offer Shield multi-cancer detection testZydus Lifesciences has partnered with Apollo Hospitals to introduce the Shield multi-cancer detection test in India, made possible through ...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsIn just a few days, the Q1 earnings season for FY27 will start. But before that will come the season of business updates. And that needs to...
- Healthcare demand is outstripping supply in Noida, says MOFSL; prefers Medanta, Max HealthcareNoida-Greater Noida is rapidly becoming a prime healthcare hub in North India, fueled by population growth and corporate expansion. Despite...
Load More
